Sonia Guillen-Bravo
Overview
Explore the profile of Sonia Guillen-Bravo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung-Delgado K, Guillen-Bravo S, Revilla-Montag A, Bernabe-Ortiz A
PLoS One
. 2015 Mar;
10(3):e0119332.
PMID: 25790076
Background: An increase in multidrug-resistant tuberculosis (MDR-TB) cases is evident worldwide. Its management implies a complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment...
2.
Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Bernabe-Ortiz A
Int J Infect Dis
. 2014 Mar;
23:20-4.
PMID: 24657270
Objectives: We aimed to assess the variation in patient body weight over time according to the treatment outcome among multidrug-resistant tuberculosis (MDR-TB) cases. Methods: This was a retrospective cohort study....
3.
Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Rios-Diaz H, Alva-Munoz J
Case Rep Hematol
. 2013 Aug;
2013:391086.
PMID: 23984123
A 37-year-old woman with history of Evans Syndrome with poor response to high-dose corticoid treatment presented to the emergency department with gastrointestinal and vaginal bleeding. The patient was later diagnosed...
4.
Chung-Delgado K, Guillen-Bravo S, Navarro-Huaman L, Quiroz-Portella R, Revilla-Montag A, Ruiz-Alejos A, et al.
Rev Chilena Infectol
. 2012 Oct;
29(4):375-81.
PMID: 23096535
Introduction: One third of the world population is affected by latent tuberculosis, with 9.4 million new cases; medical students have 2 to 50 times the probability of acquiring the infection....
5.
Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, Velez-Segovia E, Soria-Montoya A, Nunez-Garbin A, et al.
PLoS One
. 2011 Nov;
6(11):e27610.
PMID: 22110689
Background: Long-term exposure to anti-tuberculosis medication increases risk of adverse drug reactions and toxicity. The objective of this investigation was to determine factors associated with anti-tuberculosis adverse drug reactions in...